Skip to content
healthcare.dev

Lansoprazole

NDC 72603-313, Lansoprazole, tablet, orally disintegrating, delayed release, from NorthStar Rx LLC.

Product NDC
72603-313
Status
Listed
Labeler
NorthStar Rx LLC
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207167
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72603-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
72603-313-107260303131010 BLISTER PACK in 1 CARTON (72603-313-10) / 10 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK (72603-313-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac051296-6fe3-4ab5-a001-cc3e06199a22
  • NADAC price for package 72603031310

    GET /v1/drugs/nadac/72603031310

Use it

Look up 72603-313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72603-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72603-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.